Argentina tightens regulation of healthcare products market
This article was originally published in SRA
Argentina's National Medicines, Food and Medical Technology Administration, ANMAT, has launched a programme that aims to tighten its oversight of the entire healthcare products supply chain1,2. It is focused on ensuring improved product traceability and providing better quality and safety guarantees.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.